Financials data is unavailable for this security.
View more
Year on year BioForce Nanosciences Holdings Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 485.51k to a smaller loss of 471.95k.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -71,707.58% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, cash reserves at BioForce Nanosciences Holdings Inc fell by 90.00. Cash Flow from Financing totalled 46.61k or -- of revenues. In addition the company used 46.70k for operations while cash from investing was breakeven.
Cash flow per share | -0.0123 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0705 |
---|---|
Tangible book value per share | -0.0705 |
More ▼
Balance sheet in USDView more
Current ratio | 0.0003 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼